Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Identification of the miRNA-mRNA regulatory network of Toxoplasma gondii based on RNA-seq

ABSTRACT: To explore the potential miRNA‑mRNA regulatory mechanism and relevant signaling pathways, we profiled host miRNA and mRNA levels during T.gondii infection with microarrays, bioinformatics, and integrated genomics analyses. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) was performed to validate the reliability of microarray data.The present study performed global expression analysis of 41,000 genes and 2,549 microRNAs using the Agilent Whole Human Genome 8 x 60k slide formats printed using Agilent's 60-mer SurePrint technology, respectively. Compared with the controlled cells, a total of 3,568 mRNAs were significantly differentially expressed, including 1,475 upregulated genes (fold change ≥2) and 463 downregulated genes (fold change ≤0.5).

ORGANISM(S): Homo sapiens

PROVIDER: GSE167582 | GEO | 2024/02/25

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

microRNA expression profiling of paired primary and lymph node metastatic breast cancer patients

Project description:Extracted total RNA from FFPE tissue were used for RNA labeling and hybridization on to the Agilent Human SurePrint 8 × 60k v16 miRNA microarray chip according to the manufacturer's protocol.

2020-05-31 | GSE148846 | GEO

Profiling of differentially expressed microRNAs in saliva of Parkinson’s disease patients

Project description:Five randomly selected samples of both PD and HC were analyzed using the Agilent Human miRNA microarray kit, Release 21.0,8 x 60K. This microarray contains 2570 probes for mature miRNA. Differentially expressed miRNAs were then identified through fold change analysis and student’s t-test. Threshold criteria were set as follows: threshold set for up- and down-regulated genes was a fold change >= 2.0 and a P value <= 0.05.

2021-07-15 | E-MTAB-10779 | biostudies-arrayexpress

Transcription profiling of human MCL1 over-expressing B-NHL cells

Project description:To get insight into the mechanisms of MCL1-induced survival and transformation, we screened 41,000 human genes in a genome-wide gene expression profile analysis of MCL1 over-expressing B-NHL cells. Experiment Overall Design: Two-color (Cy5-CTP/ Cy3-CTP) microarray-based gene expression formats presenting high-density oligonucleotide probes printed on a single glass slide were used (Agilent technologies, Cat No# G4112A whole human genome 41K). Total RNAs from MCL1 over-expressing RAMOS RA-1 and Z-138 B-cells were labeled with Cy5-CTP, whereas RNAs from references (empty vector/ RAMOS RA-1 and empty vector/ Z-138 B-cells) were labeled with Cy3-CTP. After competitive hybridization [RNA-Cy5 from MCL1 over-expressing RAMOS RA-1 or MCL1 over-expressing Z-138 versus RNA-Cy3 from either empty vector/ RAMOS RA-1 or empty vector/ Z-138 respectively] gene expression data were pre-processed using Feature Extraction software and GEPAS tools (http://gepas.bioinfo.cipf.es/).

2008-06-16 | E-GEOD-8834 | biostudies-arrayexpress

Agilent SurePrint G3 Mouse GE V2.0 Microarray(8*60K,Design ID:074809)

Project description:Agilent SurePrint G3 Mouse GE V2.0 Microarray(8*60K,Design ID:074809)

| PRJNA699158 | ENA

gene expression of KYSE510 cells with treatment of 100 nM PAF for 24 hours

Project description:KYSE510 cells were treated with 100 nM PAF for 24 hours,and then KYSE510 cells were collected for gene expression analysis using Agilent SurePrint G3 Human Gene Expression v3 (8×60K) Microarray. Investigation of the gene network of KYSE510 cells regulated by PAF.

2023-12-16 | GSE163355 | GEO

Gene expression of KYSE410 cells with treatment of 10 uM FAK inhibitor (defactinib) for 4 hours and 24 hours

Project description:KYSE410 cells were treated with 10 uM defactinib for 4 hours and 24 hours,and KYSE410 cells were collected for gene expression analysis using Agilent SurePrint G3 Human Gene Expression v3 (8×60K) Microarray. Investigation of the critical gene of KYSE410 cells treated by defactinib.

2022-07-07 | GSE155591 | GEO

SMARCA4 reads PRMT1-mediated H4R3me2a to promote colorectal cancer progression I

Project description:To further investigate the functional associations between PRMT1 and SMARCA4 and explore the biological significance of these interactions, we conducted expression profiling on the Agilent SurePrint G3 Human Gene Expression v3 (8*60K,Design ID:072363) using knockdown of PRMT1 or SMARCA4’s RNA in HCT116 cells.

2020-01-07 | GSE143198 | GEO

SMARCA4 reads PRMT1-mediated H4R3me2a to promote colorectal cancer progression II

2020-01-07 | GSE143199 | GEO

Genomewide miRNA profiling of colorectal cancer cell lines and colorectal cancer-derived induced pluripotent cancer cell lines

Project description:To establish a genomewide miRNA profile of colorectal cancer-derived induced pluripotent cancer cell lines (CRC-iPC). CRC-iPC clones and two parental cell lines were subjected to miRNA microarray analysis using SurePrint Human MiRNA Microarray Release 21.0 (Agilent). In order to identify the differentially-expressed miRNAs after OSKM-reprogramming, the miRNA expression of CRC-iPCs was relatively compared to that of parental colorectal cancer cell lines. Using a stringent selection criteria of log2(fold change) (FC) ≥ 2.0 or < -2.0 and p-value < 0.05, a total of 102 statistically significant differentially-expressed miRNAs were identified. Amongst the 102 miRNAs, 50 miRNAs were down-regulated and 52 miRNAs were up-regulated. Four miRNAs (miR-362-5p, miR-532-3p, miR-125b-5p, and miR199a-3p) were randomly selected for validation by quantitative real-time PCR, the results were consistent with that of the microarray results. To establish a genomewide miRNA profile of colorectal cancer-derived induced pluripotent cancer cell lines (CRC-iPC). CRC-iPC clones and two parental cell lines were subjected to miRNA microarray analysis using SurePrint Human MiRNA Microarray Release 21.0 (Agilent). In order to identify the differentially-expressed miRNAs after OSKM-reprogramming, the miRNA expression of CRC-iPCs was relatively compared to that of parental colorectal cancer cell lines. Using a stringent selection criteria of log2(fold change) (FC) ≥ 2.0 or < -2.0 and p-value < 0.05, a total of 102 statistically significant differentially-expressed miRNAs were identified. Amongst the 102 miRNAs, 50 miRNAs were down-regulated and 52 miRNAs were up-regulated. Four miRNAs (miR-362-5p, miR-532-3p, miR-125b-5p, and miR199a-3p) were randomly selected for validation by quantitative real-time PCR, the results were consistent with that of the microarray results.

2018-07-31 | GSE87280 | GEO

Qualitative differences in diseases-associated mutants reveal molecular signatures and aberrant signaling-crosstalk

Project description:We generated HEK293 cells stably expressing diseases-derived mutants and performed a genome-wide transcriptome analysis using the 60K SurePrint G3 Human gene expression microarray technology. By the analysis of their gene expression profiles, we identified diseases-associated signature genes that may serve as diagnostic markers or therapeutic targets for the diseases.

2022-06-13 | GSE165823 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data